- MCA filings & documents
- P&L, balance sheet, cash flow & ratios
- Year-wise charts & analysis
- One credit = one full company report
- Use across any company, anytime
- Credits valid for 12 months
Key Metrics
Company Health Scores
Health scores for Genesys Biologics covering vendor trust, statutory compliance, financial health and director risk - derived from MCA filings, GST and EPFO records, financial statements and the company's board history.
- Blend of compliance (51), financial health (30), director (55) and company-foundation signals.
- Operating for 11+ years.
- Company status is Active as per MCA.
- Last balance sheet filed for Mar 2024 - slightly behind.
- Loss-making in FY 2023.
- Negative net worth - capital eroded by losses.
- 5 directors on the board.
- Director KONDRELLA ROOPESH has DIN status "Deactivated due to non-filing of DIR-3 KYC".
About Genesys Biologics
Genesys Biologics is an MCA-registered Indian company: a Private Limited Indian Non-Government Company (CIN U24232TG2014PTC096432). Business overview includes Life Sciences (Biotechnology), incorporated on November 18, 2014 (12+ years old), headquartered in Hyderabad, Telangana, India. The company is currently Active with Active Compliant compliance status.
- Location 6-3-248/1/1/A, 4Th Floor Bhaskar Plaza, Road No1,Banjara Hills, Hyderabad, Telangana - 500034
- Website genesysbiologics.com
Financial Performance of Genesys Biologics
| Metrics | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Profit/Loss | — | — | — | — | — |
| Cash & Bank Balance | — | — | — | — | — |
| Net Worth | — | — | — | — | — |
| EBITDA | — | — | — | — | — |
Financial Ratios
Sign in to view ratio trends
| Ratio | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| Net Profit Margin | — | — | — | — | — |
| Debt to EBITDA | — | — | — | — | — |
| Interest Coverage Ratio | — | — | — | — | — |
| Debt to Equity | — | — | — | — | — |
| Return on Equity | — | — | — | — | — |
| Current Ratio | — | — | — | — | — |
| Quick Ratio | — | — | — | — | — |
| EBITDA Margin | — | — | — | — | — |
| Return on Capital Employed | — | — | — | — | — |
| Earning Per Share | — | — | — | — | — |
EPFO Establishments (1)
Current Directors of Genesys Biologics (5)
Charges of Genesys Biologics
| Lender | Amount | Status |
|---|---|---|
|
State Bank Of India
Creation Date: 03 Aug 2018 |
11.00 cr | Closed |
|
Others
Creation Date: 07 Sep 2017 |
22.50 Lakh | Closed |
|
State Bank Of India
Creation Date: 21 Jul 2017 |
58.50 cr | Open |
Business Activity
| Activity Group | Description | Turnover % |
|---|---|---|
| Manufacturing | - | 100.00 |
Flagged By Authority
Regulatory and exchange flags (preview)
Disclaimer: Data on this page is compiled from public sources as available in our system at the time of the last update and is for general information only. Scores are derived indicators, not credit ratings or advice - please verify from official sources and consult a professional before making any business or financial decision.
